Selected research
Market Structure
Global Liposome Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Liposome Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Liposome Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Liposome Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Liposome Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Liposome Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Liposome Service include Acuitas Therapeutics, CD Bioparticles, Corden Pharma, Creative Biolabs, Creative Biostruct, Encapsula NanoSciences, Evonik, Exelead and FormuMax Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Liposome Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Liposome Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Liposome Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Liposome Service market size, projected growth trends, production technologies, key applications, and end-use industries.
Liposome Service Segment by Company
Acuitas Therapeutics
CD Bioparticles
Corden Pharma
Creative Biolabs
Creative Biostruct
Encapsula NanoSciences
Evonik
Exelead
FormuMax Scientific
FUJIFILM Pharmaceuticals USA
GMPriority Pharma
Lipoid
LIPOSOMA
Merck KGaA
Nippon Fine Chemical
PlantaCorp
Polymun
Liposome Service Segment by Type
Liposome Development Services
Liposome Customization Service
Liposome Encapsulation Services
Others
Liposome Service Segment by Application
Pharmaceutical
Life Sciences
Cosmetics and Skin Care Industrial
Others
Liposome Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liposome Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Liposome Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liposome Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Liposome Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Liposome Service industry.
Chapter 3: Detailed analysis of Liposome Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liposome Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Liposome Development Services
- Liposome Customization Service
- Liposome Encapsulation Services
- Others
Applications
- Pharmaceutical
- Life Sciences
- Cosmetics and Skin Care Industrial
- Others
Companies covered
- Acuitas Therapeutics
- CD Bioparticles
- Corden Pharma
- Creative Biolabs
- Creative Biostruct
- Encapsula NanoSciences
- Evonik
- Exelead
- FormuMax Scientific
- FUJIFILM Pharmaceuticals USA
- GMPriority Pharma
- Lipoid
- LIPOSOMA
- Merck KGaA
- Nippon Fine Chemical
- PlantaCorp
- Polymun
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Liposome Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Liposome Development Services
- 1.2.3 Liposome Customization Service
- 1.2.4 Liposome Encapsulation Services
- 1.2.5 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Liposome Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical
- 1.3.3 Life Sciences
- 1.3.4 Cosmetics and Skin Care Industrial
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Liposome Service Growth Trends by Region
- 1.5.1 Global Liposome Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Liposome Service Market Size by Region (2021-2026)
- 1.5.3 Liposome Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Liposome Service Market Dynamics
- 2.1 Liposome Service Industry Trends
- 2.2 Liposome Service Industry Drivers
- 2.3 Liposome Service Industry Opportunities and Challenges
- 2.4 Liposome Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Liposome Service Revenue by Company (2021-2026)
- 3.2 Global Liposome Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Liposome Service Key Company Head office and Area Served
- 3.4 Global Liposome Service Company, Product Type & Application
- 3.5 Global Liposome Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Liposome Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Liposome Service Players Market Share by Revenue in 2025
- 3.6.3 2025 Liposome Service Tier 1, Tier 2, and Tier 3
4 Liposome Service Market by Type
- 4.1 Global Liposome Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Liposome Service Market Size by Type (2021-2032)
- 4.3 Global Liposome Service Market Size Share by Type (2021-2032)
5 Liposome Service Market by Application
- 5.1 Global Liposome Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Liposome Service Market Size by Application (2021-2032)
- 5.3 Global Liposome Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Acuitas Therapeutics
- 6.1.1 Acuitas Therapeutics Company Information
- 6.1.2 Acuitas Therapeutics Business Overview
- 6.1.3 Acuitas Therapeutics Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Acuitas Therapeutics Liposome Service Product Portfolio
- 6.1.5 Acuitas Therapeutics Recent Developments
- 6.2 CD Bioparticles
- 6.2.1 CD Bioparticles Company Information
- 6.2.2 CD Bioparticles Business Overview
- 6.2.3 CD Bioparticles Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 CD Bioparticles Liposome Service Product Portfolio
- 6.2.5 CD Bioparticles Recent Developments
- 6.3 Corden Pharma
- 6.3.1 Corden Pharma Company Information
- 6.3.2 Corden Pharma Business Overview
- 6.3.3 Corden Pharma Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Corden Pharma Liposome Service Product Portfolio
- 6.3.5 Corden Pharma Recent Developments
- 6.4 Creative Biolabs
- 6.4.1 Creative Biolabs Company Information
- 6.4.2 Creative Biolabs Business Overview
- 6.4.3 Creative Biolabs Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Creative Biolabs Liposome Service Product Portfolio
- 6.4.5 Creative Biolabs Recent Developments
- 6.5 Creative Biostruct
- 6.5.1 Creative Biostruct Company Information
- 6.5.2 Creative Biostruct Business Overview
- 6.5.3 Creative Biostruct Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Creative Biostruct Liposome Service Product Portfolio
- 6.5.5 Creative Biostruct Recent Developments
- 6.6 Encapsula NanoSciences
- 6.6.1 Encapsula NanoSciences Company Information
- 6.6.2 Encapsula NanoSciences Business Overview
- 6.6.3 Encapsula NanoSciences Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Encapsula NanoSciences Liposome Service Product Portfolio
- 6.6.5 Encapsula NanoSciences Recent Developments
- 6.7 Evonik
- 6.7.1 Evonik Company Information
- 6.7.2 Evonik Business Overview
- 6.7.3 Evonik Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Evonik Liposome Service Product Portfolio
- 6.7.5 Evonik Recent Developments
- 6.8 Exelead
- 6.8.1 Exelead Company Information
- 6.8.2 Exelead Business Overview
- 6.8.3 Exelead Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Exelead Liposome Service Product Portfolio
- 6.8.5 Exelead Recent Developments
- 6.9 FormuMax Scientific
- 6.9.1 FormuMax Scientific Company Information
- 6.9.2 FormuMax Scientific Business Overview
- 6.9.3 FormuMax Scientific Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 FormuMax Scientific Liposome Service Product Portfolio
- 6.9.5 FormuMax Scientific Recent Developments
- 6.10 FUJIFILM Pharmaceuticals USA
- 6.10.1 FUJIFILM Pharmaceuticals USA Company Information
- 6.10.2 FUJIFILM Pharmaceuticals USA Business Overview
- 6.10.3 FUJIFILM Pharmaceuticals USA Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 FUJIFILM Pharmaceuticals USA Liposome Service Product Portfolio
- 6.10.5 FUJIFILM Pharmaceuticals USA Recent Developments
- 6.11 GMPriority Pharma
- 6.11.1 GMPriority Pharma Company Information
- 6.11.2 GMPriority Pharma Business Overview
- 6.11.3 GMPriority Pharma Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 GMPriority Pharma Liposome Service Product Portfolio
- 6.11.5 GMPriority Pharma Recent Developments
- 6.12 Lipoid
- 6.12.1 Lipoid Company Information
- 6.12.2 Lipoid Business Overview
- 6.12.3 Lipoid Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Lipoid Liposome Service Product Portfolio
- 6.12.5 Lipoid Recent Developments
- 6.13 LIPOSOMA
- 6.13.1 LIPOSOMA Company Information
- 6.13.2 LIPOSOMA Business Overview
- 6.13.3 LIPOSOMA Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 LIPOSOMA Liposome Service Product Portfolio
- 6.13.5 LIPOSOMA Recent Developments
- 6.14 Merck KGaA
- 6.14.1 Merck KGaA Company Information
- 6.14.2 Merck KGaA Business Overview
- 6.14.3 Merck KGaA Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Merck KGaA Liposome Service Product Portfolio
- 6.14.5 Merck KGaA Recent Developments
- 6.15 Nippon Fine Chemical
- 6.15.1 Nippon Fine Chemical Company Information
- 6.15.2 Nippon Fine Chemical Business Overview
- 6.15.3 Nippon Fine Chemical Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Nippon Fine Chemical Liposome Service Product Portfolio
- 6.15.5 Nippon Fine Chemical Recent Developments
- 6.16 PlantaCorp
- 6.16.1 PlantaCorp Company Information
- 6.16.2 PlantaCorp Business Overview
- 6.16.3 PlantaCorp Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 PlantaCorp Liposome Service Product Portfolio
- 6.16.5 PlantaCorp Recent Developments
- 6.17 Polymun
- 6.17.1 Polymun Company Information
- 6.17.2 Polymun Business Overview
- 6.17.3 Polymun Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Polymun Liposome Service Product Portfolio
- 6.17.5 Polymun Recent Developments
7 North America
- 7.1 North America Liposome Service Market Size (2021-2032)
- 7.2 North America Liposome Service Market Size by Type
- 7.2.1 North America Liposome Service Market Size by Type (2021-2026)
- 7.2.2 North America Liposome Service Market Size by Type (2027-2032)
- 7.2.3 North America Liposome Service Market Share by Type (2021-2032)
- 7.3 North America Liposome Service Market Size by Application
- 7.3.1 North America Liposome Service Market Size by Application (2021-2026)
- 7.3.2 North America Liposome Service Market Size by Application (2027-2032)
- 7.3.3 North America Liposome Service Market Share by Application (2021-2032)
- 7.4 North America Liposome Service Market Size by Country
- 7.4.1 North America Liposome Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Liposome Service Market Size by Country (2021-2026)
- 7.4.3 North America Liposome Service Market Size by Country (2027-2032)
- 7.4.4 North America Liposome Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Liposome Service Market Size (2021-2032)
- 8.2 Europe Liposome Service Market Size by Type
- 8.2.1 Europe Liposome Service Market Size by Type (2021-2026)
- 8.2.2 Europe Liposome Service Market Size by Type (2027-2032)
- 8.2.3 Europe Liposome Service Market Share by Type (2021-2032)
- 8.3 Europe Liposome Service Market Size by Application
- 8.3.1 Europe Liposome Service Market Size by Application (2021-2026)
- 8.3.2 Europe Liposome Service Market Size by Application (2027-2032)
- 8.3.3 Europe Liposome Service Market Share by Application (2021-2032)
- 8.4 Europe Liposome Service Market Size by Country
- 8.4.1 Europe Liposome Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Liposome Service Market Size by Country (2021-2026)
- 8.4.3 Europe Liposome Service Market Size by Country (2027-2032)
- 8.4.4 Europe Liposome Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Liposome Service Market Size (2021-2032)
- 9.2 China Liposome Service Market Size by Type
- 9.2.1 China Liposome Service Market Size by Type (2021-2026)
- 9.2.2 China Liposome Service Market Size by Type (2027-2032)
- 9.2.3 China Liposome Service Market Share by Type (2021-2032)
- 9.3 China Liposome Service Market Size by Application
- 9.3.1 China Liposome Service Market Size by Application (2021-2026)
- 9.3.2 China Liposome Service Market Size by Application (2027-2032)
- 9.3.3 China Liposome Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Liposome Service Market Size (2021-2032)
- 10.2 Asia Liposome Service Market Size by Type
- 10.2.1 Asia Liposome Service Market Size by Type (2021-2026)
- 10.2.2 Asia Liposome Service Market Size by Type (2027-2032)
- 10.2.3 Asia Liposome Service Market Share by Type (2021-2032)
- 10.3 Asia Liposome Service Market Size by Application
- 10.3.1 Asia Liposome Service Market Size by Application (2021-2026)
- 10.3.2 Asia Liposome Service Market Size by Application (2027-2032)
- 10.3.3 Asia Liposome Service Market Share by Application (2021-2032)
- 10.4 Asia Liposome Service Market Size by Country
- 10.4.1 Asia Liposome Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Liposome Service Market Size by Country (2021-2026)
- 10.4.3 Asia Liposome Service Market Size by Country (2027-2032)
- 10.4.4 Asia Liposome Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Liposome Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Liposome Service Market Size by Type
- 11.2.1 South America, Middle East & Africa Liposome Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Liposome Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Liposome Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Liposome Service Market Size by Application
- 11.3.1 South America, Middle East & Africa Liposome Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Liposome Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Liposome Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Liposome Service Market Size by Country
- 11.4.1 South America, Middle East & Africa Liposome Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Liposome Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Liposome Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Liposome Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst